Acute Leukaemia Group
This group aims to develop new therapeutic strategies for acute myeloid leukaemia (AML), a disease with a poor outcome for many patients. The group’s research focusses on improving understanding of the disease through studies on leukaemia stem cells and their interactions with normal haematopoietic stem cells.